For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Product sourcing reference

Tirzepatide Sourcing Review

A tirzepatide inquiry requires a current regulatory review, not a general promise of 503B office-use supply. Specify the exact product and transaction before requesting terms.

Reference variants

Add Tirzepatide to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 10mgVial · confirm physical formCAS 2023788-19-2
    $10.10/vial$8.08/vial at 1,000+ vials of this item
    vials, packs of 10
  • 30mgVial · confirm physical formCAS 2023788-19-2
    $27.17/vial$21.74/vial at 1,000+ vials of this item
    vials, packs of 10
  • 60mgVial · confirm physical formCAS 2023788-19-2
    $64.69/vial$51.75/vial at 1,000+ vials of this item
    vials, packs of 10

Review your order request · Compare the full catalog

Distinguish approved products from compounded copies

Identify the manufacturer and finished product being proposed. A compounded tirzepatide preparation is not FDA-approved merely because approved medicines contain tirzepatide.

Document the reason for the proposed pathway

Have the responsible pharmacist or clinician assess current restrictions, including the applicable rules on essentially copies. A preferred price or concentration alone should not be treated as a blanket authorization to compound.

Before a sourcing inquiry

For Tirzepatide, provide the exact substance or finished-product identity, intended transaction, facility type and destination state. Do not send patient information. A qualified reviewer must confirm the applicable pathway before purchasing.

  • Obtain product- and lot-specific identity and quality records before accepting material.
  • Verify storage, shipping and dating against the actual preparation, not a generic catalog range.
  • Request written confirmation of availability and terms; this page does not confirm stock, strength, price or supply eligibility.

We do not currently have verified COAs available to publish. No purity, sterility or lot-release result is established by this page.

Purchasing questions

Can a clinic assume tirzepatide is available for office use?

No. Facility registration and account approval do not establish that a particular tirzepatide preparation may be supplied. Confirm the current rules, source, formulation and destination requirements before proceeding.

Compare concentration, not just vial totals

A total milligram amount does not state concentration or usable volume. FDA describes dosing concerns with compounded GLP-1 drugs, making a clearly specified preparation more useful than a low price per vial.

Documentation to request

Ask for total content, concentration, fill volume and actual labeling together. Have the pharmacy reviewer verify current compounding conditions instead of relying on shortage-era marketing.

Regulatory context: FDA: unapproved GLP-1 drugs and ingredient restrictions. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Weight-loss clinic sourcing requirements. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. A compounded preparation is not FDA-approved. This reference is not medical or legal advice and does not establish a lawful supply route.

Ask about the review requirements

Ask what information is needed to assess a Tirzepatide inquiry. An inquiry is not confirmation that the product can be supplied.

Discuss sourcing requirements
Call Apply for Wholesale